Jacobs Levy Equity Management, Inc Alpine Immune Sciences, Inc. Transaction History

Jacobs Levy Equity Management, Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 15, 2022	BUY	$6.89 - $9.39 $122,318 - $166,700	17,753 New	17,753 $128,000
Q2 2022 Aug 15, 2022	SELL	$6.71 - $9.52 $927,852 - $1.32 Million	-138,279 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$6.41 - $13.89 $886,368 - $1.92 Million	138,279 New	138,279 $1.24 Million
Q3 2019 Nov 14, 2019	SELL	$3.5 - $5.0 $74,459 - $106,370	-21,274 Closed	0 $0
Q2 2019 Aug 13, 2019	BUY	$4.08 - $7.75 $86,797 - $164,873	21,274 New	21,274 $90,000

56.2K

Ticker ALPN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 44,006,700
Description
Alpine Immune Sciences, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of protein-based immunotherapies for the treatment of cancer, autoimmune/inflammatory disorders, and other diseases. Its product pipeline includes ALPN-101, an inducible T cell costimulator (ICOS)/cluster of differentiation 28 (CD28...

Get notified when there are updates to the investment portfolio of Jacobs Levy Equity Management, Inc, based on Form 13F filings with the SEC.

Stay updated on Jacobs Levy Equity Management, Inc with notifications on news.